Early research (Phase 1)Study completedNCT00001021
What this trial is testing
A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 57